$133.58
0.55% day before yesterday
NYSE, May 30, 10:12 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$133.58
+2.83 2.16% 1M
+16.77 14.36% 6M
+20.47 18.10% YTD
+31.84 31.30% 1Y
+16.89 14.47% 3Y
+40.57 43.62% 5Y
+84.64 172.95% 10Y
NYSE, Closing price Fri, May 30 2025
+0.73 0.55%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Market capitalization $232.41b
Enterprise Value $238.81b
P/E (TTM) P/E ratio 17.28
EV/FCF (TTM) EV/FCF 35.87
EV/Sales (TTM) EV/Sales 5.64
P/S ratio (TTM) P/S ratio 5.49
P/B ratio (TTM) P/B ratio 4.76
Dividend yield 1.68%
Last dividend (FY24) $2.24
Revenue growth (TTM) Revenue growth 5.00%
Revenue (TTM) Revenue $42.34b
EBIT (operating result TTM) EBIT $7.39b
Free Cash Flow (TTM) Free Cash Flow $6.66b
Cash position $6.84b
EPS (TTM) EPS $7.73
P/E forward 33.11
P/S forward 5.21
EV/Sales forward 5.35
Short interest 1.29%
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Abbott Laboratories forecast:

18x Buy
60%
11x Hold
37%
1x Sell
3%

Analyst Opinions

30 Analysts have issued a Abbott Laboratories forecast:

Buy
60%
Hold
37%
Sell
3%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
42,344 42,344
5% 5%
100%
- Direct Costs 18,589 18,589
3% 3%
44%
23,755 23,755
7% 7%
56%
- Selling and Administrative Expenses 11,748 11,748
6% 6%
28%
- Research and Development Expense 2,790 2,790
5% 5%
7%
9,217 9,217
8% 8%
22%
- Depreciation and Amortization 1,826 1,826
6% 6%
4%
EBIT (Operating Income) EBIT 7,391 7,391
12% 12%
17%
Net Profit 13,502 13,502
140% 140%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Neutral
Investors Business Daily
4 days ago
Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.
Positive
Seeking Alpha
5 days ago
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 2025 and the average growth rate at 4.75%. 22 Aristocrats appear both undervalued and offer a projected long-term annualized return of at least 10%, based on dividend yield theory and earnings growth.
Neutral
PRNewsWire
5 days ago
The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a new treatment option for patients who are not candidates for open-heart surgery or mitral repair This approval expands Abbott's portfolio of minimally invasive structural heart therapies in the U.S....
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today